본문 바로가기

연구소

연구논문 및 특허성과

  • Home
  • 연구소
  • 연구논문 및 특허성과

논문성과

암센터 국문 논문 목록
학술지 책임저자
제1저자
저자,논문명,학술지명,발간일;년도;페이지:통권(Impact Factor)
Neurocognitive and psychological functioning of pediatric brain tumor patients undergoing proton beam therapy for three different tumor types 김주영
(방사선의학연구과)
김주영:윤상희, 하보람:이은희, 박보람, 양송이, 유은승. Neurocognitive and psychological functioning of pediatric brain tumor patients undergoing proton beam therapy for three different tumor types PEDIATRIC BLOOD & CANCER. 2021-11-12; 2021; Online:Published. IF 3.167 (2020)
윤상희
(양성자치료센터)
하보람
(양성자치료센터)
Association between metabolic syndrome and its components and incident colorectal cancer in a prospective cohort study 김정선
(암의생명과학과)
김정선:Tao Thi Tran:Madhawa Gunathilake, 이정희. Association between metabolic syndrome and its components and incident colorectal cancer in a prospective cohort study CANCER. 2021-11-11; 2021; Online:Published. IF 6.86 (2020)
Tao Thi Tran
(암관리학과)
Influence of fasting glucose level on gastric cancer incidence in a prospective cohort study 김정선
(암의생명과학과)
김정선:Tao Thi Tran:Madhawa Gunathilake, 이정희, 조현순. Influence of fasting glucose level on gastric cancer incidence in a prospective cohort study CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2021-11-10; 2021; 31(1):254~261. IF 4.254 (2020)
Tao Thi Tran
(암관리학과)
Chimeric Antigen Receptor T Cells With Modified Interleukin-13 Preferentially Recognize IL13Rα2 and Suppress Malignant Glioma: A Preclinical Study Seong-Won Song
Seong-Won Song:곽호신, Kiwan Kim:한나영, 홍은경, 최범규. Chimeric Antigen Receptor T Cells With Modified Interleukin-13 Preferentially Recognize IL13Rα2 and Suppress Malignant Glioma: A Preclinical Study FRONTIERS IN IMMUNOLOGY. 2021-11-08; 2021; 12:715000~. IF 7.561 (2020)
곽호신
(희귀암센터)
Oncogenic KRAS promotes growth of lung cancer cells expressing SLC3A2-NRG1 fusion via ADAM17-mediated shedding of NRG1 신동훈
(치료내성연구과)
한지연1
(치료내성연구과)
신동훈, 한지연:신동훈:김선하, 최민영, 배영기, 한충용, 최범규, 김상수. Oncogenic KRAS promotes growth of lung cancer cells expressing SLC3A2-NRG1 fusion via ADAM17-mediated shedding of NRG1 ONCOGENE. 2021-11-06; 2021; 41(2):280~292. IF 9.867 (2020)
신동훈
(치료내성연구과)
Flashlight into the Function of Unannotated C11orf52 using Affinity Purification Mass Spectrometry 김윤희
(분자영상연구과)
김윤희, Jin Young Kim:Yeji Yang, Heeyoun Hwang:. Flashlight into the Function of Unannotated C11orf52 using Affinity Purification Mass Spectrometry JOURNAL OF PROTEOME RESEARCH. 2021-11-05; 2021; 20(12):5340~5346. IF 4.466 (2020)
Yeji Yang, Heeyoun Hwang
Clinical Effectiveness of Hypofractionated Proton Beam Therapy for Liver Metastasis from Breast Cancer 김태현
(방사선의학연구과)
김태현:김태현,이근석,심성훈:김연주,김대용,채희정, 이은경,한재홍, 정소연,이시연,강한성,이은숙. Clinical Effectiveness of Hypofractionated Proton Beam Therapy for Liver Metastasis from Breast Cancer FRONTIERS IN ONCOLOGY. 2021-11-03; 2021; 11:783327~. IF 6.244 (2020)
김태현
(방사선의학연구과)
이근석
(유방암센터)
A Comparative Analysis of the Perception of Cancer Patients and Healthcare Providers (Oncology Physicians, Nurses, Social Workers) in Support of Integrated Community-Linked Cancer Plans 장윤정
(암관리정책부)
장윤정:김영애:최민지, 윤이화, 정소연, 박아경, 최혜리. A Comparative Analysis of the Perception of Cancer Patients and Healthcare Providers (Oncology Physicians, Nurses, Social Workers) in Support of Integrated Community-Linked Cancer Plans INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH. 2021-11-02; 2021; 18(21):11517~. IF 3.39 (2020)
김영애
(암관리정책부)
Expert consensus on the management of adverse events in patients receiving lenvatinib for hepatocellular carcinoma Do Young Kim
Do Young Kim:김보현:. Expert consensus on the management of adverse events in patients receiving lenvatinib for hepatocellular carcinoma JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. 2021-11-01; 2021; Online:Published. IF 4.029 (2020)
김보현
(표적치료연구과)
Genomic Instability of Circulating Tumor DNA as a Prognostic Marker for Pancreatic Cancer Survival: A Prospective Cohort Study 공선영
(표적치료연구과)
공선영:우상명, 김민경:박보람, 김윤희, 최원영, 한성식, 이우진, 박상재. Genomic Instability of Circulating Tumor DNA as a Prognostic Marker for Pancreatic Cancer Survival: A Prospective Cohort Study CANCERS. 2021-10-30; 2021; 13(21):5466~. IF 6.639 (2020)
우상명
(종양면역연구과)
김민경
(표적치료연구과)